Manufacturing News of Note—Thermo Fisher closes on GSK plant; Vetter invests $100M; Lupin names ex-Apotex exec head of quality

Waltham, Massachusetts-based Thermo Fisher Scientific has completed its €90 million buyout of a GlaxoSmithKline API site in Cork, Ireland. Release

German CDMO Vetter says it will invest $100 million to upgrade its production lines at sites in Germany and the U.S. to increase filling capacity. Story

Lupin, which has been struggling with manufacturing quality, has named as its new global head of quality Johnny Mikell. He comes from Apotex, another drugmaker with a history of FDA manufacturing issues. Release

Lupin has received a Form 483 with three observations for its Tarapur plant. Story

South Plainfield, New Jersey-based biotech PTC Therapeutics has struck a deal with Aldevron to manufacture its gene therapy portfolio. Release

Boehringer Ingelheim has completed a $76 million expansion at its plant at Athens, Georgia, which doubles its pet vaccine capacity. Release

Merck KGaA’s MilliporeSigma has acquired for an undisclosed amount Wilbraham, Massachusetts-based FloDesign Sonics, which has developed an acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing. Release